Literature DB >> 12494471

Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.

Yaping Wang1, Waltraut Friedl, Christof Lamberti, Matthias Jungck, Micaela Mathiak, Constanze Pagenstecher, Peter Propping, Elisabeth Mangold.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is often caused by a deficiency in DNA mismatch repair. By using conventional methods of mutation analysis, point mutations in the DNA mismatch repair genes MSH2 and MLH1 have been detected in up to 64% of patients suspected of HNPCC. However, large genomic deletions cannot be detected by these methods. In our study, we applied a semiquantitative multiplex PCR to detect the proportion of large deletions in patients meeting the Bethesda criteria whose tumours exhibited microsatellite instability (MSI). Of 368 unrelated patients, 180 exhibited MSI. In these patients, 68 disease-causing point mutations (38%) had previously been detected in the MSH2 and MLH1 genes by SSCP, heteroduplex analysis or DHPLC followed by direct sequencing. The remaining 112 patients (including 24 patients with rare missense or other unclarified variants) were examined for large deletions. We identified deletions in 19 patients (10.6%); 11/19 (58%) deletions were located in MSH2 and 8/19 (42%) in MLH1, respectively. The size of deletions ranged from 1 exon to a deletion of a whole gene. Five breakpoints of deletions were sequenced; Alu-repetitive elements were involved in all of them. In patients meeting the Amsterdam criteria the proportion of large deletions was 12.6%. A similar proportion of deletions was found in the group of patients with a positive family history for colorectal cancer and MSI tumours, not meeting the Amsterdam criteria. The results of our study suggest that large genomic deletions in both MSH2 and MLH1 genes play a considerable role in the pathogenesis of HNPCC and should be part of the routine HNPCC mutation detection protocols. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12494471     DOI: 10.1002/ijc.10869

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  A complex rearrangement in the APC gene uncovered by multiplex ligation-dependent probe amplification.

Authors:  Constanze Pagenstecher; Dorothea Gadzicki; Dietlinde Stienen; Siegfried Uhlhaas; Elisabeth Mangold; Nils Rahner; Mine Arslan-Kirchner; Peter Propping; Waltraut Friedl; Stefan Aretz
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

Authors:  Constanze Pagenstecher; Maria Wehner; Waltraut Friedl; Nils Rahner; Stefan Aretz; Nicolaus Friedrichs; Marlies Sengteller; Wolfram Henn; Reinhard Buettner; Peter Propping; Elisabeth Mangold
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

4.  Multiple factors insulate Msh2-Msh6 mismatch repair activity from defects in Msh2 domain I.

Authors:  Charanya Kumar; Sarah C Piacente; Justin Sibert; Andrew R Bukata; Jaime O'Connor; Eric Alani; Jennifer A Surtees
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

Review 5.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

6.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

7.  LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome.

Authors:  E Volikos; J Robinson; K Aittomäki; J-P Mecklin; H Järvinen; A M Westerman; F W M de Rooji; T Vogel; G Moeslein; V Launonen; I P M Tomlinson; A R J Silver; L A Aaltonen
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

8.  Partial duplication of MSH2 spanning exons 7 through 14 in Lynch syndrome.

Authors:  Mikio Shiozawa; Yasuyuki Miyakura; Makiko Tahara; Kazue Morishima; Hidetoshi Kumano; Koji Koinuma; Hisanaga Horie; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda; Kenji Gonda; Seiichi Takenoshita; Akihiko Tamura; Noriyoshi Fukushima; Kokichi Sugano
Journal:  J Gastroenterol       Date:  2013-04-18       Impact factor: 7.527

9.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

10.  Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification.

Authors:  D J Bunyan; D M Eccles; J Sillibourne; E Wilkins; N Simon Thomas; J Shea-Simonds; P J Duncan; C E Curtis; D O Robinson; J F Harvey; N C P Cross
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.